These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 577467)

  • 1. Absorption studies with the anti-diarrhoeal agent ethacridine lactate in laboratory animals and man.
    Rising TJ; Fromson JM; McEwen J; Johnson P
    Arzneimittelforschung; 1977; 27(4):872-8. PubMed ID: 577467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further absorption studies with the anti-diarrhoeal agent ethacridine lactate in the dog.
    Rising TJ; Fromson JM; Johnson P
    Arzneimittelforschung; 1978; 28(4):631-5. PubMed ID: 581939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of labetalol by animals and man.
    Martin LE; Hopkins R; Bland R
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The absorption of [G-3H]-acetylglycyrrhetate after oral administration to rats.
    Cameron BD; Chasseaud LF; Hawkins DR; McCormick DJ
    Arzneimittelforschung; 1976; 26(9):1680-3. PubMed ID: 1036700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic fate of the new cardiotonic denopamine in animals. 1st communication: absorption, distribution and excretion in the rat, rabbit and dog.
    Naito K; Furuuchi S; Yamada Y; Otsuka M; Harigaya S
    Arzneimittelforschung; 1986 Apr; 36(4):643-51. PubMed ID: 3718588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of nitrendipine. I. Absorption, plasma concentrations, and excretion after single administration of [14C]nitrendipine to rats and dogs.
    Krause HP; Ahr HJ; Beermann D; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Nov; 38(11):1593-9. PubMed ID: 3214442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 5: the pharmacokinetics of loperamide in rats and man.
    Heykants J; Michiels M; Knaeps A; Brugmans J
    Arzneimittelforschung; 1974 Oct; 24(10):1649-53. PubMed ID: 4479779
    [No Abstract]   [Full Text] [Related]  

  • 11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 4-acetylaminophenylacetic acid. 1st communication: absorption, distribution, metabolism and excretion in mice, rats, dogs and monkeys after single administration of 14C-labeled compound.
    Sugihara K; Morino A; Nomura A; Iida S; Sugiyama M
    Arzneimittelforschung; 1990 Jul; 40(7):800-5. PubMed ID: 2222556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antilipidemic drugs. Part 4: The metabolic fate of the hypolipidemic agent isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-protionate (LF 178) in rats, dog and man.
    Brodie RR; Chasseaud LF; Elson FF; Franklin ER; Taylor T
    Arzneimittelforschung; 1976; 26(5):896-901. PubMed ID: 989365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption, distribution, metabolism and excretion of telmesteine, a mucolitic agent, in rat.
    Lee J; Son J; Rhee SW; Kim DH
    Xenobiotica; 2003 Jul; 33(7):755-65. PubMed ID: 12893524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution and excretion of (3H)vincristine in the rat and the dog.
    Castle MC; Margileth DA; Oliverio VT
    Cancer Res; 1976 Oct; 36(10):3684-9. PubMed ID: 953993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic fate of the new anti-ulcer drug enprostil in animals. 1st communication: absorption, distribution and excretion in the mouse, rat and rabbit.
    Smith S; Teitelbaum P; Bowen L; Tomlinson R; Berry P; Yani A; Parnes H; Chaplin M
    Arzneimittelforschung; 1989 Mar; 39(3):335-41. PubMed ID: 2502986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of ketoprofen (19.583 R.P.) in man using the tritiated compound.
    Delbarre F; Roucayrol JC; Amor B; Ingrand J; Bourat G; Fournel J; Courjaret J
    Scand J Rheumatol Suppl; 1976; 1976(0):45-52. PubMed ID: 1068515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans.
    Vickers S; Duncan CA; Arison BH; Davies RO; Ferguson R; Zacchei AG
    Drug Metab Dispos; 1980; 8(3):163-7. PubMed ID: 6104580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary studies on the absorption, distribution and excretion of N-(2-hydroxyethyl)-maleopimarimidyl morpholide (3H-RU 18492) in the female rat and dog.
    James GW; Ramm PJ; Taylor JB; Luscombe DK; Nicholls PJ
    Arzneimittelforschung; 1976; 26(12):2193-7. PubMed ID: 1037273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.